ArticleFrontiers in oncology2026

Impact of bone-targeting agents on the clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab: a sub-analysis of the Meet-URO 15 study.

Francesco Pantano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.